Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
89.4M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
+448K
-
Total reported value, excl. options
-
$187M
-
Value change
-
+$9.68M
-
Put/Call ratio
-
0.71
-
Number of buys
-
23
-
Number of sells
-
-15
-
Price
-
$9.19
Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q3 2022
59 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares as of Q3 2022.
Milestone Pharmaceuticals Inc. - Common Shares (MIST) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 89.4M outstanding shares and own 22.81% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.32M shares), VR Adviser, LLC (2.43M shares), RA CAPITAL MANAGEMENT, L.P. (2.25M shares), Novo Holdings A/S (2M shares), MORGAN STANLEY (1.24M shares), MILLENNIUM MANAGEMENT LLC (933K shares), Ikarian Capital, LLC (856K shares), BOXER CAPITAL, LLC (699K shares), GREAT POINT PARTNERS LLC (675K shares), and Paradigm Biocapital Advisors LP (634K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.